SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-213689
Filing Date
2022-08-05
Accepted
2022-08-05 16:49:47
Documents
9
Effectiveness Date
2022-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 d357710ds8.htm S-8 60086
2 EX-5.1 d357710dex51.htm EX-5.1 6751
3 EX-23.1 d357710dex231.htm EX-23.1 2576
4 EX-99.1 d357710dex991.htm EX-99.1 26277
5 EX-99.2 d357710dex992.htm EX-99.2 16409
6 EX-99.3 d357710dex993.htm EX-99.3 25038
7 EX-99.4 d357710dex994.htm EX-99.4 15906
8 EX-FILING FEES d357710dexfilingfees.htm EX-FILING FEES 16020
9 GRAPHIC g357710g77h63.jpg GRAPHIC 7679
  Complete submission text file 0001193125-22-213689.txt   181056
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266601 | Film No.: 221141503
SIC: 2836 Biological Products, (No Diagnostic Substances)